Sciatic nerve extension complicating continuous femoral blockade [3]

Anaesthesia and Intensive Care

Volumn 34, Issue 5, 2006, Pages 684-685

  Cornet, C ^a   Compere V ^a   Fourdrinier, V ^a   Lignot, S ^a   Dujardin, F ^a   Dureuil, B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

LIDOCAINE; ROPIVACAINE;

ADOLESCENT; ANESTHESIA INDUCTION; ARTERIOGRAPHY; BLOOD VESSEL CATHETERIZATION; BODY WEIGHT; CANCER CHEMOTHERAPY; CASE REPORT; CONTINUOUS EPIDURAL ANESTHESIA; DRUG ACCUMULATION; DRUG RESPONSE; FEMALE; FEMORAL NERVE; FEMUR; HEMATOMA; HUMAN; INFUSION RATE; LETTER; LOCAL ANESTHESIA; LUMBOSACRAL PLEXUS; MAXIMUM PERMISSIBLE DOSE; MOTOR DYSFUNCTION; MOTOR NERVE BLOCK; NERVE BLOCK; NERVE COMPRESSION; NEUROTOXICITY; OBTURATOR NERVE; OSTEOSARCOMA; SCIATIC NERVE; TOTAL KNEE REPLACEMENT;

ADOLESCENT; ANESTHETICS, LOCAL; ARTHROPLASTY, REPLACEMENT, KNEE; BONE NEOPLASMS; FEMALE; FEMORAL NERVE; HUMANS; NERVE BLOCK; OSTEOSARCOMA; PAIN MEASUREMENT; SCIATIC NERVE;

EID: 33750605284     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (6)

1. Winnie AP, Ramamurthy S, Durrani Z. The inguinal paravascular technic of lumbar plexus anesthesia: the "3-in-1 block". Anesth Analg 1973; 52:989-996.
2. Singelyn FJ, Contreras V, Gouverneur JM. Epidural anesthesia complicating continuous 3-in-1 lumbar plexus blockade. Anesthesiology 1995; 83:217-220.
3. Capdevila X, Biboulet P, Morau D et al. Continuous three-in-one block for postoperative pain after lower limb orthopedic surgery: where do the catheters go? Anesth Analg 2002; 94:1001-1006.
4. Gaertner E, Choquet O, Marcaire P, Zetlaoui PJ, eds. Anesthésie régionale. Paris, Amette 2001; 144.
5. Compère V, Comet C, Fourdrinier V et al. Evaluation of continuous nerve block for postoperative pain management in orthopaedic surgery. Ann Fr Anesth Reanim 2005; 24:795-801.
6. Verstappen CC, Heimans JJ, Hoekman K, Postma TJ. Neurotoxic complications of chemotherapy in patient with cancer: clinical signs and optimal management. Drugs 2003; 63:1549-1563.